LAJA IBRAHEEM: Open Payments
NPI 1811983232 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$213 in 6 payments from 4 companies in 2025. Trend: 2023 $1,494 · 2024 $66 · 2025 $213
Food & beverage: $213
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $136 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: CAPLYTA, INGREZZA, AUSTEDO XR, COBENFY.
Industry payments across CA — which companies pay providers there.
